Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5.

导出 LinkOut

翻译打印收藏纠错

第一作者： Huriye,Ercan

第一单位： Center for Physiology and Pharmacology, Institute of Vascular Biology and Thrombosis Research, Medical University of Vienna, Vienna, Austria.

作者： Huriye,Ercan ^[1] ; Waltraud Cornelia,Schrottmaier ^[1] ; Anita,Pirabe ^[1] ; Anna,Schmuckenschlager ^[1] ; David,Pereyra ^[1] ; Jonas,Santol ^[2] ; Erich,Pawelka ^[1] ; Marianna T,Traugott ^[2] ; Christian,Schörgenhofer ^[3] ; Tamara,Seitz ^[3] ; Mario,Karolyi ^[4] ; Jae-Won,Yang ^[3] ; Bernd,Jilma ^[3] ; Alexander,Zoufaly ^[5] ; Alice,Assinger ^[4] ; Maria,Zellner ^[3]

作者单位： Center for Physiology and Pharmacology, Institute of Vascular Biology and Thrombosis Research, Medical University of Vienna, Vienna, Austria. ^[1] Division of Visceral Surgery, Department of General Surgery, General Hospital Vienna, Medical University of Vienna, Vienna, Austria. ^[2] Department of Medicine IV, Clinic Favoriten, Vienna, Austria. ^[3] Department of Clinical Pharmacology, Medical University of Vienna, General Hospital Vienna, Vienna, Austria. ^[4] Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Vienna, Austria. ^[5]

关键词 COVID-19 annexin A5 antiphospholipid syndrome coagulation factor XIII (FXIII, F13A1)eukaryotic initiation factor (EIF4A1)integrin αIIbβ3 platelets thrombosis

DOI 10.3389/fcvm.2021.779073

PMID 34859078

发布时间 2023-09-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in cardiovascular medicine

2021年8卷

779073页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5.

Frontiers in cardiovascular medicine

相似文献

Frontiers in cardiovascular medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5.

Frontiers in cardiovascular medicine

相似文献

Frontiers in cardiovascular medicine

相关期刊

检索历史清除